Relmada Therapeutics (RLMD): Sending The Right Signals?

Shares of Relmada Therapeutics Inc. (RLMD) have gained 19 percent so far this year and trade around $37.

from RTT - Biotech https://ift.tt/2WjEA4j
via IFTTT